- Home
- SCKT vs RNAZ Comparison
SCKT vs RNAZ Comparison
Compare SCKT & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCKT
- RNAZ
- Stock Information
- Founded
- SCKT 1992
- RNAZ 2016
- Country
- SCKT United States
- RNAZ United States
- Employees
- SCKT N/A
- RNAZ N/A
- Industry
- SCKT Computer Manufacturing
- RNAZ Biotechnology: Pharmaceutical Preparations
- Sector
- SCKT Technology
- RNAZ Health Care
- Exchange
- SCKT Nasdaq
- RNAZ Nasdaq
- Market Cap
- SCKT 7.5M
- RNAZ 8.7M
- IPO Year
- SCKT 1995
- RNAZ 2021
- Fundamental
- Price
- SCKT $0.99
- RNAZ $10.71
- Analyst Decision
- SCKT
- RNAZ Strong Buy
- Analyst Count
- SCKT 0
- RNAZ 1
- Target Price
- SCKT N/A
- RNAZ $280.00
- AVG Volume (30 Days)
- SCKT 26.1K
- RNAZ 421.9K
- Earning Date
- SCKT 10-22-2025
- RNAZ 11-14-2025
- Dividend Yield
- SCKT N/A
- RNAZ N/A
- EPS Growth
- SCKT N/A
- RNAZ N/A
- EPS
- SCKT N/A
- RNAZ N/A
- Revenue
- SCKT $15,945,520.00
- RNAZ N/A
- Revenue This Year
- SCKT $8.62
- RNAZ N/A
- Revenue Next Year
- SCKT N/A
- RNAZ N/A
- P/E Ratio
- SCKT N/A
- RNAZ N/A
- Revenue Growth
- SCKT N/A
- RNAZ N/A
- 52 Week Low
- SCKT $0.82
- RNAZ $6.15
- 52 Week High
- SCKT $1.72
- RNAZ $504.97
- Technical
- Relative Strength Index (RSI)
- SCKT 52.22
- RNAZ 38.66
- Support Level
- SCKT $0.92
- RNAZ $10.90
- Resistance Level
- SCKT $1.01
- RNAZ $13.92
- Average True Range (ATR)
- SCKT 0.04
- RNAZ 0.92
- MACD
- SCKT 0.00
- RNAZ -0.48
- Stochastic Oscillator
- SCKT 78.50
- RNAZ 2.75
About SCKT Socket Mobile Inc.
Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.